|
HS Code |
325991 |
| Chemical Formula | C8H5NOS |
| Molar Mass | 163.197 g/mol |
| Appearance | Yellow - orange solid |
| Melting Point | 66 - 68 °C |
| Boiling Point | 304.8 °C at 760 mmHg |
| Solubility In Water | Insoluble |
| Solubility In Organic Solvents | Soluble in common organic solvents like ethanol, dichloromethane |
| Odor | Characteristic, pungent odor |
| Flash Point | 138.1 °C |
| Density | 1.34 g/cm³ |
As an accredited Benzothiazole-2-Carboxaldehyde factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | 100g of Benzothiazole - 2 - Carboxaldehyde packaged in a sealed, chemical - resistant bottle. |
| Shipping | Benzothiazole - 2 - Carboxaldehyde is shipped in well - sealed containers, following strict chemical transportation regulations. Special care is taken to prevent exposure to heat, moisture, and incompatible substances during transit. |
| Storage | Benzothiazole - 2 - Carboxaldehyde should be stored in a cool, dry, well - ventilated area. Keep it away from heat sources, open flames, and oxidizing agents. Store in a tightly sealed container to prevent exposure to air and moisture, which could lead to degradation. It is advisable to store it separately from incompatible substances in a designated chemical storage area. |
|
Benzothiazole-2-carboxaldehyde is introduced as a dry, free-flowing crystalline solid with a melting point of 72–74°C into the synthesis train of aldose reductase inhibitors. The aldehyde functionality participates in a Reissert-type addition with ethyl 2-bromoacetate under strictly anhydrous tetrahydrofuran at −10°C, forming a chiral β-hydroxy ester intermediate that is subsequently cyclized to a thiazolidinedione pharmacophore. The upstream raw material is subjected to residual water determination by Karl Fischer titration (ASTM E203-16) before charging; moisture levels exceeding 0.15% w/w trigger a pre-drying step with molecular sieves 4A to prevent yield erosion from premature ester hydrolysis. In the key condensation, the molar ratio is held at 1.08:1 (aldehyde: bromoester), a narrow window identified through design-of-experiment runs on a 50 L glass-lined reactor equipped with a retreat-curve impeller. Deviation beyond 1.15:1 generates a dimeric byproduct that crystallizes in the workup and proves difficult to purge by recrystallization from isopropanol/water. The crude intermediate is carried forward to a hydrogenation step over 5% Pd/C (Type 487, Johnson Matthey) at 3 barg hydrogen pressure, then converted to the free acid and resolved via diastereomeric salt formation with (1S,2R)-(+)-ephedrine. The resulting active pharmaceutical ingredient conforms to residual solvent limits per ICH Q3C(R8) and is released against a Certificate of Analysis that includes assay by non-aqueous titration (Ph.Eur. 2.2.20), enantiomeric purity by chiral HPLC (USP <621> column L51), and heavy metals by ICP-MS (USP <233> Procedure 1). Equipment cleaning validation follows FDA 21 CFR 211.67 with swab recovery studies conducted in a dedicated campaign facility; cross-contamination risk is managed through a worst-case MACO calculation anchored at 1/1000th of the therapeutic dose. The production campaign typically yields 22–26 kg of micronized API per batch, compressed into HDPE drums with double LDPE liners and stored under nitrogen at 15–25°C. This intermediate is not considered a formulation excipient and is consumed entirely in the synthesis of the final drug substance, which is processed into 20 mg and 50 mg oral tablets for the management of diabetic neuropathy. What Drives Process Selectivity When Benzothiazole-2-Carboxaldehyde Enters Chiral Amide Fungicide Routes?Manufacture of valinamide carbamate fungicides structurally related to benthiavalicarb-isopropyl subjects the heterocyclic aldehyde to a high-yield oxidation pathway rather than reductive amination. The conversion to benzothiazole-2-carboxylic acid is executed in a 1000 L Hastelloy C-276 reactor using a catalytic system of 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO) and sodium hypochlorite at pH 9.2 ± 0.3. A process FTIR probe (Mettler Toledo ReactIR 15) tracks the disappearance of the aldehyde carbonyl stretch at 1708 cm⁻¹; the endpoint is called when the signal intensity drops below 0.5% of the initial peak area. The benzothiazole-2-carboxylic acid is isolated as a filter cake with a loss-on-drying specification of 0.5% max (DIN EN 15926:2011, method A1) and then coupled with L-valine isopropyl ester hydrochloride using N,N′-dicyclohexylcarbodiimide and 1-hydroxybenzotriazole in dichloromethane. The molar input ratio of activated acid to amine is precisely 1.00:1.02; excess amine is scavenged post-reaction by a resin-bound isocyanate quench (Si-DIA, SiliaBond). Impurity profiling by UPLC-QToF identifies a process-specific impurity — the corresponding benzothiazole-2-carboxamide — which is controlled below 0.10% area by extracting the organic phase with 5% w/v aqueous citric acid at 10°C. The technical concentrate is formulated as a 250 g/L suspension concentrate (SC) after wet-milling to a particle size Dv90 of 4.0 µm (Malvern Mastersizer 3000) and stabilized with an alkyl naphthalene sulfonate dispersant. The formulated product must pass CIPAC MT 184 (suspensibility), MT 161 (persistent foam), and MT 148 (wet sieve residue) per FAO/WHO Specification 575/SC (May 2020). Toxicological compliance is demonstrated through a 500 lot toxic batch release against EU Regulation 1107/2009 Annex II data points, with particular attention to the alert for mutagenic potential screened by Ames test (OECD 471). The active ingredient is packed in UN-certified fiber drums and applied at 1.5–2.0 L/ha in potato late blight management programs. Laboratories that query biological thiol homeostasis require a chromogenic or fluorogenic reporter that discriminates cysteine from homocysteine and glutathione without HPLC separation. Benzothiazole-2-carboxaldehyde is dissolved in anhydrous dimethyl sulfoxide to yield a 10 mM stock solution that is stored over activated 4A molecular sieves in a septum-sealed amber vial under argon. A working derivatization solution is prepared fresh daily by diluting the stock 1000-fold into 50 mM phosphate-buffered saline (pH 7.40 ± 0.05) to a final aldehyde concentration of 10 µM. The aldehyde condenses with the N-terminal cysteine amino group of reduced glutathione via a Schiff base mechanism that is accelerated by ultrasound-assisted vortexing at 40 kHz for 90 seconds; the resulting thiazolidine adduct exhibits an excitation maximum at 385 nm and emission at 468 nm with a quantum yield of 0.31 ± 0.02 against quinine sulfate standard (0.1 M H₂SO₄). Interference from sulfite and ascorbate is eliminated by adding 50 µM N-ethylmaleimide as a blocking agent. The calibration curve spans 0.1–50 µM glutathione with a coefficient of determination R² > 0.998 when read on a Tecan Spark multimode plate reader at a gain of 80. Detection limit, calculated as three standard deviations of the blank divided by slope, sits at 48 nM, which is sufficient for lysate and deproteinized plasma samples. While this method is not a regulated clinical diagnostic, laboratories adhering to ISO/IEC 17025:2017 for method validation employ an internal quality control spiked at 5 µM and 20 µM, analyzing Shewhart charts to flag between-run drift. The derivatized samples are photostable for only 45 minutes under ambient fluorescent lighting; extended reading protocols mandate a temperature-controlled autosampler rack at 4°C. End users deploy this chemistry in microtiter-plate format ready-to-use kits labeled “for research use only,” packed with desiccant pouches and exclusive of preservatives to avoid adduct quenching. When Alkaline Dye-Bath Stability Demands Benzothiazole-Functionalized StilbenesContinuous polyester fiber brightening in a pad-steam process exposes the optical brightener to 6.5 g/L sodium hydroxide and 190°C thermofixation; stilbene-triazine bridges degrade rapidly unless the chromophore is extended with a benzothiazole-2-yl substituent. The precursor benzothiazole-2-carboxaldehyde is condensed with 2-cyanomethylbenzothiazole in N-methyl-2-pyrrolidone at 145°C in the presence of piperidine acetate, utilizing an aldehyde-to-nitrile molar ratio of 2.00:1.05. The bis-styrylbenzene core is halogenated downstream to yield a greenish-yellow powder that exhibits maximum fluorescence at 436 nm when measured on a Datacolor Spectraflash SF600 with a D65/10° illuminant geometry. The raw optical brightener is milled on a Netzsch LME 4 horizontal bead mill to a particle size D50 of 0.8 µm and incorporated into a 25% w/w aqueous dispersion using a naphthalene sulfonate-formaldehyde condensate dispersant. On-mill tests on a Monforts Montex stenter at 12 m/min with a pick-up of 70% demonstrate a whiteness index (CIE WI-CIE, ISO 105-J02:1997) of 157 at an applied concentration of 0.15% optical brightener on weight of fabric (owf). The textile auxiliaries formulator must respect a strict boundary: the brightener dispersion cannot be co-applied with perborate or percarbonate bleach boosters above 0.5 g/L active oxygen in the pad liquor, else the thiazole ring undergoes oxidative fission and triggers a hypsochromic shift visible as yellowness under UV. Regulatory acceptance in articles destined for the European market requires compliance with REACH Annex XVII Entry 72 (CMR restricted substances) and the OEKO-TEX Standard 100 Appendix 4 limits for extractable heavy metals. The finished article is tested for extractable formaldehyde (EN ISO 14184-1:2011) and primary aromatic amines (EN 14362-1:2017) to ensure the brightener does not decompose into regulated cleavage products during garment wear. The compound is marketed as a dry powder in 25 kg fiber drums and finds use in high-tenacity polyester sportswear, automotive upholstery, and PET nonwoven sunblinds. HDI Copper Electroplating Leveler Chemistry and Via Fill UniformityThrough-blind via metallization in high-density interconnect printed circuit boards requires a leveler that suppresses copper deposition on the surface while promoting bottom-up fill in 75–100 µm diameter microvias. Benzothiazole-2-carboxaldehyde is dissolved in isopropyl alcohol and diluted into the make-up carrier solution at a tank concentration of 2.0–5.0 mg/L, where it functions as a polarizer additive alongside 40–60 mg/L polyethylene glycol (Mw 8000) and 25–40 mg/L bis-(3-sulfopropyl) disulfide brightener. The aldehyde’s lone pair on the thiazole nitrogen coordinates to Cu⁺ at the cathode diffusion layer, forming a transient film that raises the cathodic overpotential by 30–45 mV at 2.0 A/dm², as measured by a rotating disk electrode at 2000 rpm in a Metrohm Autolab PGSTAT 302N setup. Potential drop at via bottom is monitored via a shorting resistance tracer on a Yokogawa WT310E power analyzer; a leveler dose below 1.5 mg/L collapses the potential gradient and promotes mid-board voiding, visible in cross-section micrographs as hourglass-shaped copper deposits. Process control labs titrate the aldehyde concentration by UV absorbance at 263 nm after solid-phase extraction of interfering brightener components using a C18 Sep-Pak cartridge, following an in-house method validated for recovery between 95–105% at the 2 mg/L spike level. The electroplating line operates at 25 ± 1°C with continuous filtration through a 1 µm polypropylene wound cartridge and air agitation at 0.3–0.5 Nm³/h per tank. Adhesion of the electrodeposited copper is qualified after a 288°C solder float for 10 seconds (IPC-TM-650 method 2.6.8), while via fill percentage is evaluated by scanning electron microscopy on potted coupons per IPC-6012E Class 3 requirements, demanding a fill height exceeding 80% with no more than 5% void area. Environmental compliance for the finished bare board mandates RoHS Directive 2011/65/EU verification by energy-dispersive X-ray fluorescence (Fischerscope X-RAY XDLM 237) for Pb, Hg, Cd, Cr(VI), PBBs, and PBDEs below permitted thresholds. The aldehyde leveler is consumed primarily through cathodic reduction and drag-out, with a replenishment rate of 0.4–0.8 L of a 0.5 g/L dosing solution per 10,000 ampere-hours of charge passed, carefully tracked to avoid an accumulation above 8 mg/L where dendritic nodulation appears at high-current-density edges. |
Competitive Benzothiazole-2-Carboxaldehyde prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615651039172 or mail to sales9@bouling-chem.com.
We will respond to you as soon as possible.
Tel: +8615651039172
Email: sales9@bouling-chem.com
Flexible payment, competitive price, premium service - Inquire now!
| Parameter | Specification | Analytical Method |
|---|---|---|
| Assay (anhydrous basis) | ≥98.0% | HPLC‑UV, 254 nm |
| Melting Point | 72.0–74.0 °C | Differential Scanning Calorimetry (DSC), 10 K/min |
| Water Content | ≤0.5% | KF coulometric, ASTM E203‑16 |
| Residual Solvents | Ethanol ≤5000 ppm, Toluene ≤890 ppm | Headspace GC‑FID, USP <467> |
| Appearance | Pale yellow crystalline powder | Visual, 25 °C |
| Benzothiazole Impurity | ≤1.0% | HPLC, same conditions as assay |
| Identification (FTIR) | Conforms to reference spectrum; peaks at 1685 cm⁻¹ (C=O), 3050 cm⁻¹ (aromatic C‑H) | KBr pellet, 4000‑400 cm⁻¹ |
| Property | Benzothiazole‑2‑Carboxaldehyde | Benzothiazole‑2‑Carboxylic Acid | 2‑Aminobenzothiazole |
|---|---|---|---|
| CAS | 6639-57-2 | 3622-60-6 | 136-95-8 |
| Functional Group at C‑2 | –CHO (aldehyde) | –COOH (carboxylic acid) | –NH₂ (primary amine) |
| pKa (conjugate acid where applicable) | N/A (no acidic proton) | ~2.5 (carboxylic acid proton) | Conjugate acid pKa 4.0‑4.5 (reported range) |
| Key Reaction Mode | Condensation with amines/hydrazines; nucleophilic addition | Activation to acid chloride, then amide/ester formation; salt formation | Diazotization; N‑acylation; azo coupling |
| Oxidative Stability | Sensitive; oxidizes to the acid under air | Stable; further decarboxylation only at elevated temperature | Oxidation leads to colored degradation products; store away from strong oxidizers |
| Typical Synthetic Utility | Gatekeeper to imine‑based ligands, fluorescent probes, and reductive amination products | Direct precursor of carboxamide herbicides and pharmaceutical intermediates | Building block for azo dyes, vulcanization accelerators, and heterocyclic fused systems |